Inflammation a Culprit in Long COVID Heart Problems Prospective study illuminates mechanisms of lingering heart issues after mild COVID-19 Sep 08, 2022
Full-Dose Anticoagulation Cuts VTE in Severe COVID-19 But is it worthwhile without a mortality benefit? Trials present complex picture Aug 31, 2022
Doubling Up on Heart Drugs May Delay Aortic Damage From Marfan Syndrome Meta-analysis settles the confusion around angiotensin receptor blockers Aug 29, 2022
Perfusion Tests Comparable as Second-Line Diagnostic for Chest Pain Head-to-head trial finds "interchangeable" accuracy Aug 29, 2022
Xarelto Risky in Rheumatic Heart Disease Ischemic event prevention didn't pan out in INVICTUS trial Aug 28, 2022
PCI Flops for Ischemic LV Dysfunction With Coronary Artery Disease Randomized trial provides "definitive" evidence against revascularizing stable cases Aug 27, 2022
After Cardiac Arrest, No 'Best' Blood Pressure, Oxygen Target BOX trial finds targets aiming to boost perfusion held no advantage Aug 27, 2022
Polypill Proves Its Mettle for Heart Protection Post-MI Trial affirms benefit of single drug-combo pill compared with usual care in secondary prevention Aug 26, 2022
Stronger Antiplatelet Better for VTE Prophylaxis After Joint Replacement Trial shows enoxaparin superiority as sole prophylaxis, but based largely on below-the-knee DVT Aug 23, 2022
Two Strikes and Monoclonal Antibodies Are Out for Early Parkinson's? Failure of two agents in two phase II trials could spell the end for one avenue of treatment Aug 03, 2022